【摘 要】
：
Development of multidrug resistance against chemotherapeutic drugs is one of the major obstacles to successful cancer therapy in the clinic.Thus far,amphiphilic polymeric micelles and chemosensitizers
【机 构】
：
Department of Pharmacy,Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University,Guangzhou 510120,Guangdo
论文部分内容阅读
Development of multidrug resistance against chemotherapeutic drugs is one of the major obstacles to successful cancer therapy in the clinic.Thus far,amphiphilic polymeric micelles and chemosensitizers have been used to overcome multidrug resistance in cancer.The goals of this study were to prepare poly(ethylene glycol)-bock-poly(lactide)(PEG2k-PLA5k)micelles for co-delivery of the chemotherapeutic drug doxorubicin(DOX)with a chemosensitizer curcumin(CUR),investigate the potential of the dual drug-loaded micelles((DOX+CUR)-Micelles)to reverse multidrug resistance,and explore the underlying mechanisms.(DOX+CUR)-Micelles were prepared using an emulsion solvent evaporation method.The cellular uptake,drug efflux,down-regulation of P-glycoprotein expression and inhibition of ATP activity of(DOX+CUR)-Micelles were studied in drug-resistant MCF-7/ADR cells.In vitro analyses demonstrated that(DOX+CUR)-Micelles were superior to free DOX,free drug combination(DOX+CUR),and DOX-loaded micelles in inhibiting proliferation of MCF-7/ADR cells.This effect of(DOX+CUR)-Micelles was partially attributable to their highest cellular uptake,lowest efflux rate of DOX,and strongest effects on down-regulation of P-glycoprotein and inhibition of ATP activity.Additionally,(DOX+CUR)-Micelles showed increased tumor accumulation and strong inhibitory effect on tumor growth in the xenograft model of drug-resistant MCF-7/ADR cells compared to that of other drug formulations.These results indicate that(DOX+CUR)-Micelles display potential for application in the therapy of drug-resistant breast carcinoma.
其他文献
目的：采用阴阳离子静电沉积技术制备一种新型的口服胰岛素微球制剂.方法：以溶剂挥发法制备聚乳酸(poly lactic acid,PLA)微球作为载体,采用阴阳离子静电沉积技术通过静电引力在载体表面多层沉积胰岛素,制备载胰岛素微球;用扫描电镜和粒度仪分别观察测定载药微球的形态和粒径;进行正交实验,以载药量(drug loading rate,DL)来优化制备工艺;建立高效液相色谱(High Perf
We performed a systematic review to evaluate pharmacokinetics changes of drugs when concomitantly used with voriconazole(until Jan,2016).Among 41 studies included in our search,17 were randomized cros
目的：通过文献评价对利拉鲁肽治疗2型糖尿病的药物经济学进行评估.方法：系统检索PubMed,Value in Health,PharmacoEconomics等英文数据库文章和CNKI、万方、维普等中文数据库文章,根据标准筛选文献并对研究结果进行分析.结果：共纳入21篇第三方支付角度的经济学文献,其中2篇来自中国.分别是利拉鲁肽与艾塞那肽、西格列汀、格列美脲和罗格列酮等药物进行比较,研究涉及的国家
利西那肽是一种皮下注射使用的GLP-1受体激动剂,主要用于经饮食和锻炼控制血糖,效果不佳的成人2型糖尿病的辅助治疗.本品最常见的不良反应为恶心、呕吐、头痛、腹泻、晕眩等.本文通过对利西那肽进行文献检索,对其药理作用、药代动力学、临床评价、安全性、用法用量和药物相互作用进行综述.
目的：利用适应性进化与基因工程结合的策略提高酿酒酵母细胞内谷胱甘肽(Glutathione,GSH)产量.方法：对工程菌株进行适应性进化,得到GSH高产菌株,比较进化菌株与原养型菌株代谢物相对浓度差异,对进化菌株中积累的代谢中间体进行分流,提高细胞内GSH产量.结果：经过两轮适应性实验室进化,筛选得到GSH产量为245mg/L的进化菌株;代谢组分析显示进化菌株中GSH合成的前体的相对浓度均有上升,
中国医疗卫生支出持续提高，2010-2015年卫生总支出复合增长率15.2％，以此增长率预测2020年总规模将达到8.2万亿元。
1例60岁女性冠心病、急性非ST段抬高型心肌梗死患者行经皮冠脉介入治疗,术后0.4 mg/h静脉泵入替罗非班注射液.15小时后,患者出现鼻腔渗血以及皮下出血点.血小板示 PLT 1×109/L,凝血功能未见明显异常,考虑为替罗非班导致的血小板减少,立即停用所有抗血小板药物.停药后患者血小板计数逐渐回升,6天后血小板计数恢复至137×109/L.
介绍了心衰低钠的病理生理。心衰时激活的神经激素对肾小管心衰患者血浆AVP(血管加压素)不恰当增高，心衰低钠的发病机理：心衰伴低钠，与不良临床结局，相关心衰患者血钠水平与累计生存率关系等。
心衰恶化和住院的主要原因。Chaudhry等人研究：因心衰而住院的患者在住院前30田体重就开始增加。而未住院的患者体重没有明显变化(P＜0.001)人类去除体液潴留的探索西方油画中关于放血的描绘2014年中国心衰指南-推荐的利尿剂利尿药作用位点和分类.
The combination of a chemotherapeutic drug with a chemosensitizer has emerged as a promising strategy for cancers showing multidrug resistance(MDR).Herein we describe the simultaneous targeted deliver